Luis E. Raez, MD, incoming president of the Florida Society of Clinical Oncology, provides an overview of his goals for his upcoming term.
Luis E. Raez, MD, incoming president of the Florida Society of Clinical Oncology, provides an overview of his goals for his upcoming term.
Transcript:
What are some of your goals as the incoming president of FLASCO?
As a new president of FLASCO, we have several goals. We are working with 12 industry partners in statewide projects that benefit cancer therapy outcomes and patients. For example, one of the projects I love the most because I’m a lung cancer doctor is lung cancer screening. Statewide we only screen 5% of all the patients that are at risk of having lung cancer. It is our goal to increase significantly that proportion. So that is one of the important projects that we have. We have other projects regarding access to drugs, payment of drugs, healthcare outcomes [and] most of these projects involve patient care and quality care.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
AUA Session Highlights the General Urologist’s Role in Gender-Affirming Care
May 7th 2024During her session, Polina Reyblat, MD, Kaiser Permanente Los Angeles Medical Center, highlighted best practices urologists should incorporate to make transgender and gender-diverse patients comfortable during physical exams and avoid retraumatization.
Read More
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Posters Detail Effects—and Uncertainty—of Drug Pricing Negotiations
May 7th 2024Research into the Inflation Reduction Act evaluated payer concerns, patient and physician behavior, which patients will benefit from the first 10 drugs selected for price negotiation, and the ripple effect into Medicaid at the state level.
Read More